Autoantibodies to vimentin different modifications in patients with tuberculosis and different granulomatous lung diseases

A. Malkova (Saint Petersburg, Russian Federation), A. Starshinova (Saint Petersburg, Russian Federation), S. Lapin (Saint Petersburg, Russian Federation), E. Surkova (Saint Petersburg, Russian Federation), J. Zinchenko (Saint Petersburg, Russian Federation), N. Basantsova (Saint Petersburg, Russian Federation), B. Gildburd (Tel Hashomer, Israel), P. Yablonskiy (Saint Petersburg, Russian Federation)

Source: International Congress 2019 – Tuberculosis: diagnosis
Session: Tuberculosis: diagnosis
Session type: Thematic Poster
Number: 3016
Disease area: Respiratory infections

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Malkova (Saint Petersburg, Russian Federation), A. Starshinova (Saint Petersburg, Russian Federation), S. Lapin (Saint Petersburg, Russian Federation), E. Surkova (Saint Petersburg, Russian Federation), J. Zinchenko (Saint Petersburg, Russian Federation), N. Basantsova (Saint Petersburg, Russian Federation), B. Gildburd (Tel Hashomer, Israel), P. Yablonskiy (Saint Petersburg, Russian Federation). Autoantibodies to vimentin different modifications in patients with tuberculosis and different granulomatous lung diseases. 3016

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Utility of myositis related antibodies in interstitial lung disease and suspected autoimmunity.
Source: International Congress 2019 – From biomarkers to treatment of immune-mediated interstitial lung disease: what’s new?
Year: 2019


Comparison of smear positive tuberculosis features in males with and without chronic lung diseases
Source: Annual Congress 2010 - Adverse events of antituberculosis treatment and comorbidities
Year: 2010

Evaluating the use of the interferon-γ response to mycobacterium tuberculosis (MTB) specific antigens to diagnose latent tuberculosis infection in patients with chronic inflammatory joint and skin diseases
Source: Annual Congress 2011 - Tuberculin skin tests, interferon-gamma release assays and beyond
Year: 2011

Autoantibodies in interstitial lung disease
Source: International Congress 2017 – The spectrum of CTDs: from pathogenesis to treatment
Year: 2017


The characteristics of mycobacterioses in patients with chronic lung diseases
Source: International Congress 2019 – Airway infection in COPD
Year: 2019

The comparison of the manifestation of systemic inflammation in patients with minor forms of tuberculosis and pulmonary sarcoidosis
Source: Annual Congress 2009 - Clinical tuberculosis
Year: 2009

Connective tissue disease-associated interstitial lung diseases and interstitial pneumonia with autoimmune features: different entities?
Source: Virtual Congress 2020 – Diagnostic and prognostic markers for disease-associated interstitial lung disease and hypersensitivity pneumonitis
Year: 2020


Comparison of registries of interstitial lung diseases in three European countries
Source: Eur Respir J 2001; 18: 114S-118S
Year: 2001



Autoantibodies in patients treated for active pulmonary tuberculosis
Source: Eur Respir J 2003; 22: Suppl. 45, 159s
Year: 2003

Nine cases of interstitial lung disease associated with anti-CADM140 antibody positive dermatomyositis
Source: Annual Congress 2012 - Diffuse parenchymal lung disease: clinical profiles and collagen vascular disease
Year: 2012


Over-expression of thymosin beta4 in granulomatous lung lesions in active pulmonary tuberculosis
Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: diagnostic tools
Year: 2012

The pulmonary microbiome in sarcoidosis is similar to other parenchymal lung diseases
Source: International Congress 2018 – Sarcoidosis: from basic research to patient outcomes
Year: 2018



Clinical and pathological findings of patients with interstitial lung diseases associated with antisynthetase other than Jo-1 antibodies
Source: Eur Respir J 2005; 26: Suppl. 49, 541s
Year: 2005

Myositis-specific antibodies identify a distinct interstitial pneumonia with autoimmune features phenotype
Source: Eur Respir J, 56 (6) 2001205; 10.1183/13993003.01205-2020
Year: 2020



Autoantibodies to the surfactant protein D in patients with interstitial lung diseases associated with amyopathic dermatomyositis and systemic sclerosis
Source: Annual Congress 2008 - Interstitial lung disease in systemic and vascular disorders
Year: 2008

BAL protein profiles specific of different interstitial lung diseases
Source: Annual Congress 2012 - Diffuse parenchymal lung disease: clinical profiles and collagen vascular disease
Year: 2012

Clinical significance of different cytokines expression in lung tissue in idiopathic fibrosing alveolitis (IFA) and lung sarcoidosis
Source: Eur Respir J 2002; 20: Suppl. 38, 313s
Year: 2002

Clinical characteristics of 30 patients with interstitial pneumonia associated with anti-aminoacyl-tRNA-synthetase antibodies
Source: International Congress 2016 – Connective tissue disorders
Year: 2016


Silica exposure, silicosis, autoimmune diseases, tuberculosis and nontuberculous pulmonary mycobacterial disease
Source: International Congress 2016 – Occupational epidemiology
Year: 2016